Fatigue and cancer: Causes, prevalence and treatment approaches

L. I. Wagner; D. Cella

doi:10.1038/sj.bjc.6602012

Fatigue and cancer: Causes, prevalence and treatment approaches

L. I. Wagner^*, D. Cella

^*Corresponding author for this work

Medical Social Sciences

Research output: Contribution to journal › Short survey › peer-review

291 Scopus citations

Abstract

Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncology patients with fatigue are reviewed. Both nonpharmacologic and pharmacologic strategies for the management of fatigue are summarised.

Original language	English (US)
Pages (from-to)	822-828
Number of pages	7
Journal	British Journal of Cancer
Volume	91
Issue number	5
DOIs	https://doi.org/10.1038/sj.bjc.6602012
State	Published - Aug 31 2004

Keywords

Cancer symptom management
Cancer-related fatigue

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.bjc.6602012

Cite this

@article{3e2164d1af984e06a6990173e5b9596a,

title = "Fatigue and cancer: Causes, prevalence and treatment approaches",

abstract = "Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncology patients with fatigue are reviewed. Both nonpharmacologic and pharmacologic strategies for the management of fatigue are summarised.",

keywords = "Cancer symptom management, Cancer-related fatigue",

author = "Wagner, {L. I.} and D. Cella",

year = "2004",

month = aug,

day = "31",

doi = "10.1038/sj.bjc.6602012",

language = "English (US)",

volume = "91",

pages = "822--828",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Fatigue and cancer

T2 - Causes, prevalence and treatment approaches

AU - Wagner, L. I.

AU - Cella, D.

PY - 2004/8/31

Y1 - 2004/8/31

N2 - Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncology patients with fatigue are reviewed. Both nonpharmacologic and pharmacologic strategies for the management of fatigue are summarised.

AB - Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncology patients with fatigue are reviewed. Both nonpharmacologic and pharmacologic strategies for the management of fatigue are summarised.

KW - Cancer symptom management

KW - Cancer-related fatigue

UR - http://www.scopus.com/inward/record.url?scp=4644227840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644227840&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6602012

DO - 10.1038/sj.bjc.6602012

M3 - Short survey

C2 - 15238987

AN - SCOPUS:4644227840

SN - 0007-0920

VL - 91

SP - 822

EP - 828

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 5

ER -

Fatigue and cancer: Causes, prevalence and treatment approaches

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this